These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 533231)

  • 21. [Evaluation of novel assays for the detection of crosslinked fibrin degradation products in whole blood by the agglutination of the red blood cells].
    Kuroso K; Isogai N; Koike K; Fukutake K; Fujimaki M
    Rinsho Byori; 1992 Dec; 40(12):1281-6. PubMed ID: 1307633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unreliability of current serum fibrin degradation product (FDP) assays.
    Gaffney PJ; Perry MJ
    Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination.
    Proietti AB; Johnson MJ; Proietti FA; Repke JT; Bell WR
    Obstet Gynecol; 1991 May; 77(5):696-700. PubMed ID: 2014082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of the laboratory diagnosis of hypercoagulability].
    Vorlová Z; Dyr JE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):450-5. PubMed ID: 6083910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Critical evaluation of new methods for studying fibrin degradation products].
    Prisco D
    Recenti Prog Med; 1989 May; 80(5):263-7. PubMed ID: 2669062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibrin degradation products in pregnant women with nephropathies].
    Tsitsiashvili ESh
    Sov Med; 1982; (2):113-4. PubMed ID: 7063962
    [No Abstract]   [Full Text] [Related]  

  • 27. Parallel determinations of FDP and fibrin monomers with various methods.
    Hedner U; Nilsson IM
    Thromb Diath Haemorrh; 1972 Oct; 28(2):268-79. PubMed ID: 4674239
    [No Abstract]   [Full Text] [Related]  

  • 28. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
    Sigal SH; Cembrowski GS; Shattil SJ; Brown NM; Schifreen RS; Schwartz MW
    Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-dimer test and diagnosis of deep vein thrombosis: a comparative study of 7 assays.
    Elias A; Aptel I; Huc B; Chalé JJ; Nguyen F; Cambus JP; Boccalon H; Boneu B
    Thromb Haemost; 1996 Oct; 76(4):518-22. PubMed ID: 8902989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. False-negative test for fibrinogen--fibrin degradation products.
    Kickler T; Bell WR
    Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
    Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of D-dimer using a new fully automated assay: its application for the diagnosis of deep vein thrombosis.
    Villa P; Ferrando F; Serra J; Faus H; Mira Y; Vayá A; Aznar J
    Haematologica; 2000 May; 85(5):520-4. PubMed ID: 10800170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary evaluation of two new rapid immunoturbidimetric D-dimer assays in patients with clinically suspected venous thromboembolism (VTE).
    Houbouyan-Reveillard LL; Mihoubi A; Houdijk WP; Qanadli S; Joseph T; Courret JP; Page B; Goguel AF
    Thromb Haemost; 2000 Nov; 84(5):770-4. PubMed ID: 11127853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The detection of D-dimer in plasma by enzyme immunoassay: improved discrimination is obtained with a more specific signal antibody.
    Hart R; Bate I; Dinh D; Elms M; Bundesen P; Hillyard C; Rylatt DB
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):227-32. PubMed ID: 7519890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological assay and radioimmunoassay of FDP on human serum (author's transl)].
    Abe K
    Rinsho Byori; 1978; 26(4):313-21. PubMed ID: 671777
    [No Abstract]   [Full Text] [Related]  

  • 37. Significance of increased fibrin/fibrinogen degradation products and presence of fibrin monomers in pregnant women.
    Svanberg L; Eydal A; Astedt B
    Ann Chir Gynaecol Suppl; 1977; 66(5):247-50. PubMed ID: 596808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of the use of glutaraldehyde for the sensitization of red cells in Merskey's technic].
    Quichaud C; de Cacqueray-Joigny C; Etcharry F; Moras M; Chatelan M; Boisseau M; Bentegeat J
    Pathol Biol (Paris); 1974 Nov; 22 suppl():92-6. PubMed ID: 4219981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.